Company Filing History:
Years Active: 2008
Title: Innovations in Neuropsychiatric Treatment by Samuel Gershon
Introduction
Samuel Gershon is an accomplished inventor based in Fox Chapel, PA (US). He has made significant contributions to the field of neuropsychiatric disorders through his innovative research and patented methods. His work focuses on the development of compounds and compositions that aim to improve mental health outcomes.
Latest Patents
Gershon holds a patent for "Compounds, compositions and methods for treating neuropsychiatric disorders." This patent highlights the use of Acetyl-L-carnitine (ALCAR) and L-carnitine (LCAR) as nutraceuticals with potential applications in treating various mental health disorders. His research presents a metabolomics-guided bioprocess method that enhances the formation of LCAR and ALCAR in germinating plant seeds. By manipulating metabolic fluxes during germination in bioreactors, he increases oxygen availability and creates an aseptic environment that alters carbohydrate consumption and represses gluconeogenesis. These metabolic changes lead to an approximate 1000-fold increase in the natural production of LCAR and ALCAR by sunflower seeds. The resulting products are aimed at treating conditions such as Alzheimer's disease, geriatric depression, non-geriatric depression, and schizophrenia.
Career Highlights
Throughout his career, Samuel Gershon has focused on the intersection of biochemistry and mental health. His innovative approaches have garnered attention in the scientific community, particularly for their potential to revolutionize treatment methods for neuropsychiatric disorders. Gershon's dedication to research and development has positioned him as a key figure in this important field.
Collaborations
Gershon has collaborated with notable colleagues, including Jay W Pettegrew and Kanagasabai Panchalingam. These partnerships have further enriched his research and contributed to the advancement of knowledge in neuropsychiatric treatment.
Conclusion
Samuel Gershon's work exemplifies the potential of innovative research in addressing complex mental health issues. His patented methods and compounds represent a significant step forward in the treatment of neuropsychiatric disorders. The impact of his contributions continues to resonate within the scientific community and beyond.